# An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease

> **NCT06778265** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Shanghai UniXell Biotechnology Co., Ltd** · enrollment: 12 (estimated)

## Conditions studied

- Parkinson Disease, Idiopathic

## Interventions

- **BIOLOGICAL:** UX-DA001

## Key facts

- **NCT ID:** NCT06778265
- **Lead sponsor:** Shanghai UniXell Biotechnology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-03-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06778265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06778265, "An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06778265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*